Drug firm Cipla Ltd on Wednesday said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa. "Further to our earlier communication on the ...

New Delhi, Mar 18 () The US Food and Drug Administration (USFDA) has issued a warning letter to drug major Cipla for violating current good manufacturing practice norms at its Goa-based plant.